Understanding pancreatic cancer symptoms can help individuals seek medical attention sooner, potentially improving outcomes.

As few as one in ten people survive pancreatic cancer five years after ... very invasive procedures," Maher said. This ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the blood of someone who doesn’t have the disease. When used alongside the ...

adding that definitive diagnosis of pancreatic cancer entails a series of imaging scans, blood tests, and biopsy—and those ...

Imaging studies demonstrate diffuse dilation of the pancreatic duct and the pancreatic parenchyma ... at risk for other malignancies and should undergo colonoscopy and close cancer surveillance.

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models for significantly longer ...

imaging technologies, and extracellular vesicle isolation. Another author declared being on the executive board of the Pancreatic Cancer Early Detection Consortium, serving on scientific advisory ...

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy.

The Saint Louis University Center for Pancreatic and Biliary Diseases has been officially ... advanced laboratory testing, imaging studies and endoscopic procedures, when necessary. By offering this ...

Pancreatic cancer is a resilient killer whose survival rates have hardly improved in recent decades. It is expected to become the second biggest cause of cancer-related death globally by 2030.